# Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer

> **NCT07185308** · NA · NOT_YET_RECRUITING · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Cachexia; Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Postbiotics, 2.5 g per dose, three times per day
- **DIETARY_SUPPLEMENT:** Placebo, 2.5 g per dose, three times per day

## Key facts

- **NCT ID:** NCT07185308
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185308, "Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07185308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*